Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: Water Bioburden Estimation Method – V 2.0

Posted on By

Analytical Method Development: Water Bioburden Estimation Method – V 2.0

Standard Operating Procedure for Water Bioburden Estimation in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/127/2025
Supersedes SOP/AMD/127/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP defines the method for estimation of microbial bioburden in pharmaceutical water systems, including Purified Water (PW) and Water for Injection (WFI), using membrane filtration and standard plate count techniques in

accordance with pharmacopeial guidelines.

2. Scope

This procedure applies to the Analytical Method Development (AMD) and Microbiology departments involved in the monitoring of pharmaceutical water systems used in formulation, cleaning, and analytical testing processes.

3. Responsibilities

  • Microbiologist: Collects water samples, performs filtration, incubates media, and documents CFU counts.
  • Analytical Scientist: Coordinates with water system personnel for timely sample scheduling.
  • QA Officer: Reviews records for compliance and trends deviations or excursions.
  • Head – AMD: Ensures adherence to approved procedures and interprets results for process control.
See also  Analytical Method Development: Development of Environmental Monitoring Plates - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring that all water bioburden estimation methods meet regulatory and internal quality requirements.

5. Procedure

5.1 Sample Collection

  1. Collect samples in pre-sterilized, depyrogenated glass bottles (minimum 100 mL capacity).
  2. Sample points should include user ends, storage tanks, and critical points in the PW/WFI loop.
  3. Label with sample ID, location, date, time, and collector’s name.
  4. Transport samples to the microbiology lab within 30 minutes of collection and analyze within 2 hours.
  5. Record collection details in Annexure-1: Water Sampling Log.

5.2 Filtration and Media Preparation

  1. Use 0.45 µm sterile membrane filters for sample filtration.
  2. Filter 100 mL of sample aseptically using a membrane filtration assembly.
  3. Rinse filter with 100 mL of sterile 0.1% peptone water to eliminate residual sanitizer (if applicable).
  4. Place membrane onto:
    • Tryptic Soy Agar (TSA) for total aerobic microbial count
    • Sabouraud Dextrose Agar (SDA) for yeast and mold detection (optional)
  5. Document filtration and media usage in Annexure-2: Filtration and Plate Log.

5.3 Incubation and Enumeration

  1. Incubate TSA plates at 30–35°C for 3–5 days.
  2. Incubate SDA plates at 20–25°C for 5–7 days (if included).
  3. Observe plates daily and record colony counts.
  4. Calculate bioburden as CFU/mL: CFU/mL = Total Colonies / 100.
  5. Record results in Annexure-3: Bioburden Result Sheet.
See also  Analytical Method Development: SOP for HPLC Method for Residual API on Equipment - V 2.0

5.4 Alert and Action Limits

  1. Set limits based on type of water system:
    • Purified Water: Alert = 50 CFU/mL; Action = 100 CFU/mL
    • Water for Injection: Alert = 10 CFU/100 mL; Action = 20 CFU/100 mL
  2. Any excursion must be investigated, and a deviation or out-of-specification (OOS) report generated.
  3. Initiate CAPA and resampling where required.
  4. Document in Annexure-4: Excursion Investigation Log.

5.5 Trends and Reporting

  1. Compile monthly trend data for each sampling location.
  2. Use line graphs or control charts to identify spikes, shifts, or system deterioration.
  3. Review data in monthly quality meetings and recommend preventive actions.
  4. Archive in Annexure-5: Monthly Water Bioburden Trend Chart.

6. Abbreviations

  • PW: Purified Water
  • WFI: Water for Injection
  • CFU: Colony Forming Unit
  • TSA: Tryptic Soy Agar
  • SDA: Sabouraud Dextrose Agar
  • SOP: Standard Operating Procedure

7. Documents

  1. Water Sampling Log – Annexure-1
  2. Filtration and Plate Log – Annexure-2
  3. Bioburden Result Sheet – Annexure-3
  4. Excursion Investigation Log – Annexure-4
  5. Monthly Water Bioburden Trend Chart – Annexure-5
See also  Analytical Method Development: SOP for HPTLC Method Development - V 2.0

8. References

  • USP <1231> – Water for Pharmaceutical Purposes
  • WHO TRS 970 Annex 2 – Quality of Water in Pharmaceutical Use
  • ICH Q10 – Pharmaceutical Quality System

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Water Sampling Log

Date Sample ID Location Time Collected By
19/05/2025 WB-127-A User Point 3 09:00 AM Rajesh Kumar

Annexure-2: Filtration and Plate Log

Sample ID Volume Filtered Media Used Filter Lot Operator
WB-127-A 100 mL TSA F045-25 Sunita Reddy

Annexure-3: Bioburden Result Sheet

Sample ID Plate Count CFU/mL Limit Status
WB-127-A 3 0.03 ≤ 1.0 Pass

Annexure-4: Excursion Investigation Log

Date Sample ID CFU/mL Deviation No. CAPA
— — — — —

Annexure-5: Monthly Water Bioburden Trend Chart

[Graphical trend maintained offline. Attach to printed SOP for archival.]

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Included trend analysis and deviation tracking Annual Review
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Gel Manufacturing: SOP for Conducting Internal Audits of Gel Production – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Validation of Cleaning Processes for Sterile Equipment – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version